Diamond Institute for Infertility & Menopause

Millburn, New Jersey 07041

Medical Director: Matan Yemini, MD

Diamond Institute for Infertility & Menopause, located in Millburn, New Jersey, offers comprehensive fertility care under the guidance of Medical Director Dr. Matan Yemini. The practice provides a full range of reproductive services, including IVF, egg freezing, donor egg programs, and surrogacy coordination. With their verified lab accreditation, patients can trust in the quality and reliability of their laboratory processes and procedures.

The clinic's success rates reflect their commitment to helping families grow. For patients under 35, they achieve a 50% live birth rate, while patients ages 35-37 have a 22.2% live birth rate. In 2022, the team completed 441 treatment cycles, demonstrating their experience in guiding patients through various fertility journeys. Whether you're just beginning to explore your options or have been navigating fertility challenges for some time, Diamond Institute combines clinical expertise with personalized care to support you through this important chapter of your life.

Services Offered

IVF

In vitro fertilization — eggs are retrieved and fertilized in a lab, then transferred to the uterus.

Egg Freezing

Oocyte cryopreservation — eggs are retrieved and frozen for future use.

Donor Egg

Uses eggs from a screened donor for patients who cannot use their own.

Surrogacy

Gestational carrier arrangements — an embryo is transferred to a surrogate who carries the pregnancy.

Success Rates

Success rates reflect live births per intended egg retrieval, as reported to the CDC for the 2022 reporting year. Rates vary based on individual patient factors.

Age GroupFresh TransfersFrozen TransfersNat'l Avg
Under 3550.00%+1.642.50%48.4%
35–3722.20%-13.822.90%36%
38–4020.50%-3.128.10%23.6%
Over 40Not reported0.00%9.5%

Based on 441 total cycles reported. National averages computed across all reporting clinics.

Physicians

Nearby Clinics

Data on this page is sourced from the CDC's National ART Surveillance System (NASS) and the Society for Assisted Reproductive Technology (SART). Success rates reflect live births per intended egg retrieval for the 2022 reporting year. Individual results vary based on patient age, diagnosis, and treatment protocol.